Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

7.7%

1 terminated out of 13 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

15%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

80% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (4)
P 2 (2)
P 4 (2)

Trial Status

Completed4
Unknown3
Withdrawn2
Recruiting2
Terminated1
Not Yet Recruiting1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (13)

Research Network

Activity Timeline